Abstract. To investigate the effects of antiinflammatory steroids on in vivo prostaglandin production, urinary excretion rates of six different cyclo-oxygenase products were determined before, during, and after the administration of dexamethasone (1 mg/kg per d). Urine was collected in metabolism cages and was analyzed for prostaglandins E2 and F2a (PGE2 and PGF2a,) by radioimmunoassay after open-column chromatography; 6-ketoprostaglandin Fla (6-keto-PGFIa) and thromboxane B2 (TxB2) were determined by radioimmunoassay after organic solvent extraction and reversed-phase high performance liquid chromatography; 7a-hydroxy-5,1 1-diketo-tetranorprostane-1,16-dioic acid (PGE-M) and 5a,7a-dihydroxy-11 -keto-tetranorprostane-1,16-dioicacid (PGF-M), the major urinary metabolites of prostaglandins E and F, were determined by gas chromatography-mass spectrometry and by radioimmunoassay, respectively. Dexamethasone failed to cause a statistically significant change in the excretion rate of PGE2 (control, 250.4±40.8; dexamethasone, 297.6±78.7 ng/kg per d).In contrast, PGF2, excretion decreased during administration of dexamethasone (from 1,036±228 to 449±158 ng/kg per d; P < 0.05). The urinary excretion rates of 6-keto-PGFia, TxB2, PGE-M, and PGF-M were not significantly altered by dexamethasone. (Control and dexamethasone values were, respectively, 63.6±7.9 and 103.5±17.9 ng/kg per d for 6-keto-PGFIa; 13.0±3.0 and 14.8±2.1 ng/kgperd for TxB2; 1,251+217 and 1,905±573 ng/kg per d for PGE-M; and 4,131±611 and 4,793±600 ng/kg per d for PGF-M.) Urine flow was significantly higher during dexamethasone administration (control, 159±24; dexamethasone, 305±29 ml/24 h; P < 0.01). However, no correlation could be detected between